We have ample evidence that atypically expressed receptors for a growth factor are the very mechanisms of cancer initiation (e.g., Insulin-like growth factor receptor isoforms in lung cancer and HER2/neu in breast cancer). The gene discussed is ERBB2; the disease is cancer.